Learn More
Medchemexpress LLC Samuraciclib hydroch 25mg | 1805789-54-1 | 25MG

Supplier: Medchemexpress LLC HY103712A25MG
Samuraciclib hydrochloride (CT7001 hydrochloride) is a potent selective ATP-competitive and orally active CDK7 inhibitor with an IC50 of 41 nM Samuraciclib hydrochloride displays 45- 15- 230- and 30-fold selectivity over CDK1 CDK2 (IC50 of 578 nM) CDK5 and CDK9 respectively Samuraciclib hydrochloride inhibits the growth of breast cancer cell lines with GI50 values between 0 2-0 3 M Samuraciclib hydrochloride has anti-tumor effects[1 [2
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.